Correlation Between Summit Therapeutics and STANLN

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Summit Therapeutics and STANLN at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Summit Therapeutics and STANLN into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Summit Therapeutics PLC and STANLN 32 17 APR 25, you can compare the effects of market volatilities on Summit Therapeutics and STANLN and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Summit Therapeutics with a short position of STANLN. Check out your portfolio center. Please also check ongoing floating volatility patterns of Summit Therapeutics and STANLN.

Diversification Opportunities for Summit Therapeutics and STANLN

0.01
  Correlation Coefficient

Significant diversification

The 3 months correlation between Summit and STANLN is 0.01. Overlapping area represents the amount of risk that can be diversified away by holding Summit Therapeutics PLC and STANLN 32 17 APR 25 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on STANLN 32 17 and Summit Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Summit Therapeutics PLC are associated (or correlated) with STANLN. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of STANLN 32 17 has no effect on the direction of Summit Therapeutics i.e., Summit Therapeutics and STANLN go up and down completely randomly.

Pair Corralation between Summit Therapeutics and STANLN

Given the investment horizon of 90 days Summit Therapeutics PLC is expected to generate 89.68 times more return on investment than STANLN. However, Summit Therapeutics is 89.68 times more volatile than STANLN 32 17 APR 25. It trades about 0.11 of its potential returns per unit of risk. STANLN 32 17 APR 25 is currently generating about 0.48 per unit of risk. If you would invest  1,002  in Summit Therapeutics PLC on November 3, 2024 and sell it today you would earn a total of  1,148  from holding Summit Therapeutics PLC or generate 114.57% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy22.4%
ValuesDaily Returns

Summit Therapeutics PLC  vs.  STANLN 32 17 APR 25

 Performance 
       Timeline  
Summit Therapeutics PLC 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Summit Therapeutics PLC are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak primary indicators, Summit Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.
STANLN 32 17 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Market Crasher
Over the last 90 days STANLN 32 17 APR 25 has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, STANLN is not utilizing all of its potentials. The newest stock price disturbance, may contribute to short-term losses for the investors.

Summit Therapeutics and STANLN Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Summit Therapeutics and STANLN

The main advantage of trading using opposite Summit Therapeutics and STANLN positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Summit Therapeutics position performs unexpectedly, STANLN can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in STANLN will offset losses from the drop in STANLN's long position.
The idea behind Summit Therapeutics PLC and STANLN 32 17 APR 25 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.

Other Complementary Tools

Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Money Managers
Screen money managers from public funds and ETFs managed around the world
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites